PRION PROTEIN PEPTIDES AND USES THEREOF

(19)

(11)

EP 1 194 164 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	21.03.2007 Bulletin 2007/12

(45)	Mention of the grant of the patent:
	20.12.2006 Bulletin 2006/51

(21)	Application number: 00941708.0

(22)	Date of filing: 23.06.2000

(51)

International Patent Classification (IPC):

A61K 39/00^(2006.01)
A61K 39/395^(2006.01)
A61K 38/06^(2006.01)
C12N 5/06^(2006.01)
C07K 16/28^(2006.01)

A61K 39/40^(2006.01)
A61K 38/00^(2006.01)
G01N 33/53^(2006.01)
C07K 16/00^(2006.01)
A61K 49/00^(2006.01)

(86)	International application number:
	PCT/US2000/017455

(87)	International publication number:
	WO 2000/078344 (28.12.2000 Gazette 2000/52)

(54)	PRION PROTEIN PEPTIDES AND USES THEREOF PRION PROTEIN PEPTIDE UND DEREN VERWENDUNG PEPTIDES PROTEINIQUES DU PRION ET UTILISATIONS ASSOCIEES

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

23.06.1999 US 140634 P

(43)	Date of publication of application:
	10.04.2002 Bulletin 2002/15

(73)	Proprietor: IDEXX Laboratories Inc
	Westbrook, ME 04092 (US)

(72)	Inventors:
	CASHMAN, Neil, R. Toronto, Ontario M3B 1M5 (CA) PARAMITHIOTIS, Eustache Boucherville, Quebec J4B 1B9 (CA) SLON-USAKIEWICZ, Jacek Pointe-Claire, Quebec H9R 3T4 (CA) HAGHIGHAT, Ashkan Montreal, Quebec H3W 2C6 (CA) PINARD, Marc Montreal, Quebec H3G 1X6 (CA) LAWTON, Trebor Gorham, Maine 04038 (US)

(74)	Representative: Cornish, Kristina Victoria Joy et al
	Kilburn & Strode, 20 Red Lion Street London WC1R 4PJ London WC1R 4PJ (GB)

(56)

References cited: :

EP-A1- 0 861 900
WO-A1-93/23432
US-A- 5 750 361
US-A- 5 846 533

WO-A1-93/11155
WO-A1-99/19360
US-A- 5 773 572
US-A- 5 891 641

VORBERG I ET AL: "A Novel Epitope for the Specific Detection of Exogenous Prion Proteins in Transgenic Mice and Transfected Murine Cell Lines" VIROLOGY, ACADEMIC PRESS,ORLANDO, US, vol. 255, no. 1, 1 March 1999 (1999-03-01), pages 26-31, XP004467103 ISSN: 0042-6822
KORTH C ET AL: "PRION (PRPSC)-SPECIFIC EPITOPE DEFINED BY A MONOCLONAL ANTIBODY" NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 390, no. 6655, 6 November 1997 (1997-11-06), pages 74-77, XP002069611 ISSN: 0028-0836
CASHMAN N R ET AL: "A PRION-SPECIFIC IMMUNOLOGICAL EPITOPE" ABSTRACTS OF THE SOCIETY FOR NEUROSCIENCE, SOCIETY FOR NEUROSCIENCE, WASHINGTON, DC, US, vol. 27, no. 2, 2001, page 1743, XP001176739 ISSN: 0190-5295

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).